RRML - Point-of-care testing in diabetes management
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- April 2019 -
 
Simultaneous FLT3, NPM1 and DN... 23
Point-of-care testing in diabe... 11
To translate or not to transla... 10
Do we really need genetic test... 10
Can laboratory assays for meas... 8
Retraction of article: Correla... 7
Evaluation of antioxidant, ant... 6
N-3 polyunsaturated fatty acid... 6
Phenotypic and genotypic evalu... 6
Assessment of Serum Ischemia-m... 6

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 27(2)/2019 DOI:10.2478/rrlm-2019-0014
XML
TXT

Review

Point-of-care testing in diabetes management

Angela Cozma, Camelia Vonica, Adela Sitar-Taut, Adriana Fodor

Correspondence should be addressed to: Adriana Fodor

Abstract:

The prevalence of diabetes mellitus (DM) has rapidly increased over the last decades, reaching epidemic magnitudes, particularly in low- and middle-income countries. Point-of-care (POC) technology enables decision making near or at the site of patient care. Portable blood glucose meters and HbA1c testing are used by the healthcare provider and millions of patients with diabetes to monitor the safety and effectiveness of the diabetes treatment. However, POC capillary blood glucose and POC HbA1c testing are not recommended for diabetes diagnosis. Rather, they have been used for screening diabetes in low- and middle-income countries to decrease the disease burden.

Keywords: point-of-care, advanced medicine, monitoring systems, bedside testing

Received: 8.11.2018
Accepted: 28.1.2019
Published: 8.2.2019

 
  PDF Download full text PDF
(407 KB)
     
 
How to cite
Cozma A, Vonica C, Sitar-Taut A, Fodor A. Point-of-care testing in diabetes management. Rev Romana Med Lab. 2019;27(2):125-35. DOI:10.2478/rrlm-2019-0014